Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
Clinical trial NCT06796686 · RECRUITING
Trial details
- NCT number
- NCT06796686
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-17
- Primary completion
- 2027-01-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.